[go: up one dir, main page]

WO2006056877A3 - Utilisation de diazepine oxazolidinones comme agents antibacteriens - Google Patents

Utilisation de diazepine oxazolidinones comme agents antibacteriens Download PDF

Info

Publication number
WO2006056877A3
WO2006056877A3 PCT/IB2005/003559 IB2005003559W WO2006056877A3 WO 2006056877 A3 WO2006056877 A3 WO 2006056877A3 IB 2005003559 W IB2005003559 W IB 2005003559W WO 2006056877 A3 WO2006056877 A3 WO 2006056877A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibacterial agents
oxazolidinones
diazepine
compounds
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/003559
Other languages
English (en)
Other versions
WO2006056877A2 (fr
Inventor
Prudencio Sancon Herradura
Vara Prasad Venkata Na Josyula
Adam Robert Renslo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Priority to JP2007542355A priority Critical patent/JP2008521792A/ja
Priority to CA002589250A priority patent/CA2589250A1/fr
Priority to EP05808372A priority patent/EP1819699A2/fr
Publication of WO2006056877A2 publication Critical patent/WO2006056877A2/fr
Publication of WO2006056877A3 publication Critical patent/WO2006056877A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne une nouvelles classe de dérivés d'oxazolidinone, leur utilisation comme agents antibactériens, des compositions pharmaceutiques contenant ces composés et leurs méthodes de préparation.
PCT/IB2005/003559 2004-11-29 2005-11-17 Utilisation de diazepine oxazolidinones comme agents antibacteriens Ceased WO2006056877A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2007542355A JP2008521792A (ja) 2004-11-29 2005-11-17 抗菌薬としてのジアゼピンオキサゾリジノン
CA002589250A CA2589250A1 (fr) 2004-11-29 2005-11-17 Utilisation de diazepine oxazolidinones comme agents antibacteriens
EP05808372A EP1819699A2 (fr) 2004-11-29 2005-11-17 Utilisation de diazepine oxazolidinones comme agents antibacteriens

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63147504P 2004-11-29 2004-11-29
US60/631,475 2004-11-29

Publications (2)

Publication Number Publication Date
WO2006056877A2 WO2006056877A2 (fr) 2006-06-01
WO2006056877A3 true WO2006056877A3 (fr) 2006-07-20

Family

ID=36087659

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/003559 Ceased WO2006056877A2 (fr) 2004-11-29 2005-11-17 Utilisation de diazepine oxazolidinones comme agents antibacteriens

Country Status (4)

Country Link
EP (1) EP1819699A2 (fr)
JP (1) JP2008521792A (fr)
CA (1) CA2589250A1 (fr)
WO (1) WO2006056877A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8020889B2 (en) 2005-09-21 2011-09-20 Tk Holdings, Inc. Passive airbag venting
EP2208729A4 (fr) 2007-10-02 2011-04-27 Res Found Itsuu Lab Dérivé d'oxazolidinone avec hétérocycle à 7 chaînons

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024428A1 (fr) * 1997-11-12 1999-05-20 Pharmacia & Upjohn Company Derives d'oxazolidinone et compositions pharmaceutiques
WO2001046185A1 (fr) * 1999-12-21 2001-06-28 Pharmacia & Upjohn Company Oxazolidinones presentant une fonctionnalite sulfoximine et leur utilisation comme agents antimicrobiens
WO2003072553A1 (fr) * 2002-02-25 2003-09-04 Pharmacia & Upjohn Company N-aryl-2-oxazolidinone-5-carboxamides et leurs derives et utilisation de ces composes comme antibacteriens

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024428A1 (fr) * 1997-11-12 1999-05-20 Pharmacia & Upjohn Company Derives d'oxazolidinone et compositions pharmaceutiques
WO2001046185A1 (fr) * 1999-12-21 2001-06-28 Pharmacia & Upjohn Company Oxazolidinones presentant une fonctionnalite sulfoximine et leur utilisation comme agents antimicrobiens
WO2003072553A1 (fr) * 2002-02-25 2003-09-04 Pharmacia & Upjohn Company N-aryl-2-oxazolidinone-5-carboxamides et leurs derives et utilisation de ces composes comme antibacteriens

Also Published As

Publication number Publication date
EP1819699A2 (fr) 2007-08-22
WO2006056877A2 (fr) 2006-06-01
CA2589250A1 (fr) 2006-06-01
JP2008521792A (ja) 2008-06-26

Similar Documents

Publication Publication Date Title
WO2009137391A3 (fr) Composés de benzène sulfonamide thiazole et oxazole
WO2006086562A3 (fr) Derives de phenylazetidinone
WO2006038116A3 (fr) Agents antibacteriens
WO2008013838A3 (fr) Dérivés de pyridizinone
WO2007146248A3 (fr) Préparations de laquinimod stables
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
WO2007112014A3 (fr) Nouvelles combinaisons thérapeutiques pour le traitement de la dépression
WO2007084424A3 (fr) Traitement de l'abus de substances
WO2007130824A3 (fr) Modulateurs mglur5 v
WO2007130825A3 (fr) Modulateurs des récepteurs mglur5 vi
WO2008006795A3 (fr) Composés d'indole
WO2007130822A3 (fr) Modulateurs des récepteurs mglur5 iii
WO2007020213A3 (fr) Derives de thiazolylpiperidines
TW200626158A (en) Naphthaline derivatives
TW200639156A (en) New compounds
WO2009145591A3 (fr) Composés de phényl-pipérazine, composition pharmaceutique les comprenant, et utilisation associée
WO2007111983A8 (fr) Nouvelles combinaisons thérapeutiques pour le traitement ou la prévention de troubles psychotiques
AP2005003375A0 (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them.
WO2008038092A3 (fr) Pipéridinophényloxazolidinones substituées
WO2008019030A3 (fr) Composés d'azole modifiés en tant qu'agents anti-infectieux
WO2004087652A3 (fr) Composes d'imidazotriazine
WO2006077024A3 (fr) Derives de 5-aminoindole
WO2007099323A3 (fr) Dérivés de la quinoline
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
WO2007139833A3 (fr) Composés d'imidazo-azéphinone

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005808372

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2589250

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007542355

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2005808372

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)